Today, the President announced a new Executive Order and National Strategy for Combating Antibiotic-Resistant Bacteria (National Strategy) to address recommendations identified by the President’s Council of Advisors on Science and Technology (PCAST). As a leader in monitoring and preventing the spread of resistant infections, CDC will leverage its expertise and build on core strengths to:
- Slow the development of resistant bacteria and prevent the spread of resistant infections.
- Strengthen National One-Health surveillance efforts to combat resistance.
- Advance development and use of rapid and innovative diagnostic tests for identification and characterization of resistant bacteria.
- Improve international collaboration and capacities for antibiotic resistance prevention, surveillance, control, and antibiotic research and development.
3 Things to Know
To find out more about CDC and antibiotic resistance, read a new blog post from CDC’s Director, and see an infographic about why antibiotics are urgent and necessary, visit www.cdc.gov/drugresistance.
- This year alone, at least two million Americans will become sickened by antibiotic resistant infections, and 23,000 Americans will die.
- Antibiotic resistance costs the U.S. over $20 billion in healthcare expenses each year.
- These important plans are part of a request for $30 million for CDC’s Detect and Protect Initiative and $14 million of the National Healthcare Safety Network to ramp up this fight. These strategies and the funds needed to implement them are a down-payment to improve the nation’s ability to tackle the biggest drug-resistant threats.